• About
    • About Sutro
    • Patient Resources
    • Collaborations
    • Corporate Presentation
  • Leadership
    • Leadership Team
    • Board of Directors
    • Scientific Advisory Board
    • Clinical Advisory Board
  • Technology
    • XpressCF® and XpressCF+™ Platforms
    • Antibody-Drug Conjugates and IADCs
    • Bispecific and Engineered Antibodies
    • cGMP Facility
  • Investors
    • Company Presentation
    • Stock
    • Financials
    • Governance
    • Contact IR
    • Email Alerts
  • Pipeline
  • News
    • News Releases
    • Clinical / Scientific Presentation and Publication Highlights
    • Events
    • Events Audio Replays
  • Careers and Culture
    • The Way We Work
    • Join Our Team
    • Diversity, Equity, Inclusion and Belonging
      • DEIB Newsletter
    • Internships
    • Sutroites
    • Volunteer Opportunities
  • Contact Us

Sutro Biopharma to Participate in Three Upcoming Investor Conferences

Events, News, Presentations, Press Releases

Sutro Biopharma to Participate in Three Upcoming Investor Conferences SOUTH SAN FRANCISCO, Calif., Nov. 2, 2021 – Sutro Biopharma, Inc. (NASDAQ: STRO), a clinical-stage drug discovery, development and manufacturing company focused on the application of precise protein...

Sutro Biopharma

111 Oyster Point Blvd
South San Francisco, CA 94080
Phone: 650-881-6500
Fax: 650-553-9659

Google Map

Tweets by @sutrobio

Contact Us

General Inquires:
general@sutrobio.com
Business Inquires:
busdev@sutrobio.com
Investor Relations Inquires:
IR@sutrobio.com
Careers:
jobs@sutrobio.com

© 2022 Sutro Biopharma, Inc. – Privacy Policy
  • Follow
  • Follow
  • Follow